Acellular dermal matrices in reconstructive surgery; history, current implications and future perspectives for...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Plastic and Reconstructive Surgery

Background:

• Large-scale body defects pose significant reconstructive challenges, often exceeding autologous tissue repair capabilities.
• The development of artificial biological products has been crucial for managing these complex reconstructive needs.
• Acellular dermal matrices (ADMs) represent a significant advancement in reconstructive surgery, providing versatile repair options.

Purpose of the Study:

• To review the current scientific and clinical evidence supporting the use of acellular dermal matrices (ADMs) in various surgical fields.
• To familiarize reconstructive surgeons with the advantages and limitations associated with ADM utilization.
• To highlight the growing importance of ADMs in reconstructive surgery, particularly in oncologic breast reconstruction.

Main Methods:

• Comprehensive literature review of basic science and clinical studies on acellular dermal matrices (ADMs).
• Analysis of the evolution of ADM products, including tissue sources, product diversity, and expanding applications.
• Examination of ADM efficacy and safety profiles across a wide range of reconstructive surgical procedures.

Main Results:

• Acellular dermal matrices (ADMs) have demonstrated significant success in temporary, definitive, and staged repair of large-scale body defects.
• The range of ADM products and their applications have expanded considerably, with notable success in post-oncologic breast reconstruction.
• ADMs are increasingly recognized as a valuable tool in the reconstructive surgeon's armamentarium, offering distinct advantages over traditional methods.

Conclusions:

• Acellular dermal matrices (ADMs) are a cornerstone in specific reconstructive surgery fields, offering effective solutions for complex defects.
• Surgeons must understand the benefits and limitations of ADMs to optimize patient outcomes.
• Continued research and development are expected to further enhance the role and application of ADMs in future reconstructive practices.